On June 2, 2024, Caribou issued a press release announcing that it had “presented updated clinical data from the ongoing ANTLER Phase 1 trial that [purportedly] indicates a single dose of CB-010 . . .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback